Today news
About the same in other media
UK firm to trial T-cell Covid vaccine that could give longer immunity
Reading now: 831
An Oxfordshire-based company will soon start clinical trials of a second-generation vaccine against Covid-19, an easy-to-administer skin patch that uses T-cells to kill infected cells and could offer longer-lasting immunity than current vaccines.
Emergex was set up in Abingdon in 2016 to develop T-cell vaccines, the brainchild of Prof Thomas Rademacher, the firm’s chief executive and professor emeritus of molecular medicine at the University College London medical school.
The vaccines prime
Read more on theguardian.comAbout this in other media
Teesside factory making Covid vaccine gets £400m injection theguardian.com /3 years ago
Greece will fine over-60s €100 a month for refusing COVID-19 vaccine euronews.com /3 years ago
EU's COVID travel pass will expire nine months after last vaccine dose, says Brussels euronews.com /3 years ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
